Aspira Women's Health Inc. (AWHL) stock
AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Aspira Women's Health operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Aspira Women's Health's operating cash flow for the twelve months ending Jun 30, 2026 was -$4.56M. For fiscal 2025 it was -$7.03M. The highest annual figure on record is -$7.03M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.03M | – |
| FY2024 | Dec 31, 2024 | -$12.11M | – |
| FY2023 | Dec 31, 2023 | -$15.89M | – |
| FY2022 | Dec 31, 2022 | -$31.07M | – |
| FY2021 | Dec 31, 2021 | -$27.40M | – |
| FY2020 | Dec 31, 2020 | -$14.73M | – |
| FY2019 | Dec 31, 2019 | -$12.97M | – |
| FY2018 | Dec 31, 2018 | -$9.37M | – |
| FY2017 | Dec 31, 2017 | -$8.13M | – |
| FY2016 | Dec 31, 2016 | -$13.96M | – |
| FY2015 | Dec 31, 2015 | -$18.37M | – |
| FY2014 | Dec 31, 2014 | -$16.81M | – |
| FY2013 | Dec 31, 2013 | -$8.22M | – |
| FY2012 | Dec 31, 2012 | -$10.40M | – |
| FY2011 | Dec 31, 2011 | -$15.58M | – |
| FY2010 | Dec 31, 2010 | -$20.94M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.01M | – |
| Q1 FY2026 | Mar 31, 2026 | -$359.00K | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.98M | – |
| Q3 FY2025 | Sep 30, 2025 | -$212.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.73M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.10M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.02M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.92M | -187.9% |
| Q2 FY2024 | Jun 30, 2024 | -$3.74M | -209.5% |
| Q1 FY2024 | Mar 31, 2024 | -$4.43M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.45M | – |
| Q3 FY2023 | Sep 30, 2023 | $3.32M | – |
| Q2 FY2023 | Jun 30, 2023 | $3.42M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.71M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.08M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.52M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.30M | – |
| Q1 FY2022 | Mar 31, 2022 | -$10.17M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.65M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.00M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.49M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.26M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.76M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.07M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.41M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.50M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.87M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.44M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.54M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.11M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.30M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.29M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.42M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.36M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.15M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.79M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.77M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.42M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.76M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.74M | – |
See a number that looks wrong?